Form 4 · Filed Feb 18, 2026, 12:00 PM UTC
VRTX/VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan — EVP, Chief Commercial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | F | other | 2,283 | $488 | $1,113,556 | 19,528 |
Source: SEC EDGAR raw filing ↗ · Accession 0000875320-26-000072